Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Patients who have been on Wegovy or Zepbound through the program would face three options: Pay out of pocket at retail prices (currently $1,000-$1,300 per month) Discontinue the medication , which research suggests leads to significant weight regain Transition to an alternative covered treatment , such as bariatric surgery or other covered medications The STEP 1 extension study showed that patients who discontinued semaglutide regained approximately two-thirds of their lost weight within one year
This could be explained by the prescribing behavior, since HCT is prescribed very often in the sense of a first-line therapy
The rationale is that the two molecules are not equipotent at nominally similar doses, and the titration schedule for tirzepatide requires a fresh start to minimize GI risk
ColonBroom is not a drug
